SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001213900-22-031723
Filing Date
2022-06-08
Accepted
2022-06-08 14:26:12
Documents
1
Effectiveness Date
2022-06-08
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13602
  Complete submission text file 0001213900-22-031723.txt   14729
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: D | Act: 33 | File No.: 021-448510 | Film No.: 221003253
SIC: 2834 Pharmaceutical Preparations